14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:CTRV
Delisted

ContraVir Pharmaceuticals Inc Stock Signals

$1.23
+0 (+0%)
At Close: May 27, 2022

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 0 % )
Last Price $1.23 0 %
High/ Low $1.23 - $1.23 0%
Chg 7 Days N/A $1.23 $1.23
Chg 30 Days N/A $1.23 $1.23
Chg 12 mos -25.90 % $1.66 $1.23
Trend - 3 mos 0.96 % Width: 11.31 %
Trend - 12 mos -35.76 % Width: 131.28 %
Pred. range - 3 mos $1.12 - $1.25 -8.74 % - 1.58 %
Pred. range - 12 mos $0.414 - $0.96 -66.31 % - -22.08 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Buy Feb 24, 2022 - 66 days
Long MA avg 12 mos Buy Mar 07, 2022 - 59 days
Short/Long MA avg 12 mos Buy Mar 14, 2022 - 54 days
Pivot Short Sell May 26, 2022 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About ContraVir Pharmaceuticals Inc

ContraVir Pharmaceuticals ContraVir Pharmaceuticals, Inc. operates as a biopharmaceutical company focused on the development of antiviral drugs with a primary emphasis on the treatment of Hepatitis B virus (HBV) infections. The company is developing CMX157 and CRV431 to treat HBV infection; and FV-100, an orally available, small molecule compound for the prevention of post-herpetic neuralgia, and treatment of herpes zoster infection and acute zoster-associated pain. Contr... CTRV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT